MINI FUTURE ZERTIFIKAT LONG - JOHNSON & JOHNSON Share Price

Certificat

DE000TR3V4F1

Real-time BOERSE MUENCHEN 16:35:04 21/05/2024 BST
3.51 EUR -1.40% Intraday chart for MINI FUTURE ZERTIFIKAT LONG - JOHNSON & JOHNSON
Current month+21.09%
1 month+10.22%
Date Price Change
21/05/24 3.51 -1.40%
20/05/24 3.56 -4.81%
17/05/24 3.74 +1.63%
16/05/24 3.68 +4.25%
15/05/24 3.53 +2.92%

Real-time BOERSE MUENCHEN

Last update May 21, 2024 at 04:35 pm

More quotes

Static data

Product typeKnock-Out mit Stop Loss
Buy / SellCALL
Underlying JOHNSON & JOHNSON
Issuer HSBC
WKN TR3V4F
ISINDE000TR3V4F1
Date issued 01/06/2018
Strike 113.4 $
Maturity Unlimited
Parity 10 : 1
Emission price 2.08
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 7.8
Lowest since issue 0.83
Spread 0.01
Spread %0.29%

Company Profile

Johnson & Johnson is one of the world's leading producers of healthcare products. Net sales break down by family of products as follows: - pharmaceutical products (55.4%): drugs intended for the treatment of cardiovascular diseases, oncological diseases, gastro-intestinal illnesses, infectious, immunological, neurological, dermatological diseases, etc.; - medical products and equipment (28.9%): diagnostic systems, orthopedic and gynecological equipment, surgical materials, etc. for use by healthcare professionals; - consumer health products (15.7%): OTC drugs (Tylenol, Sudafed, Benadryl, Zyrtec, Motrin, Nicorette and other brands), health and beauty products (Aveeno, Clean & Clear, Dr. CI:Labo, Neutrogena and OGX), baby care products (Johnson's and Aveeno Baby), oral care products (Listerine), feminine hygiene products (Stayfree and Carefree and o.b.), wound care products (Band-Aid and Neosporin) etc. At the end of 2022, Johnson & Johnson has 89 manufacturing facilities located in the United States (28), North America (9), Europe (27), Africa and Asia/Pacific (25). Net sales are distributed geographically as follows: the United States (51.2%), Europe (24.7%), Asia/Pacific and Africa (17.7%) and other (6.4%).
Sector
-
More about the company

Ratings for Johnson & Johnson

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Johnson & Johnson

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
22
Last Close Price
151.3 USD
Average target price
173.3 USD
Spread / Average Target
+14.54%
Consensus